Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717
- PMID: 18985324
- PMCID: PMC3107999
- DOI: 10.1007/s00213-008-1360-z
Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717
Abstract
Rationale: Performance of cognitive tasks in nonhuman primates (NHPs) requires specific brain regions to make decisions under different degrees of difficulty or "cognitive load."
Objective: Local cerebral metabolic activity ([18F]FDG PET imaging) in dorsolateral prefrontal cortex (DLPFC), medial temporal lobe (MTL), and dorsal striatum (DStr) is examined in NHPs performing a delayed-match-to-sample (DMS) task with variable degrees of cognitive load.
Materials and methods: Correlations between cognitive load and degree of brain metabolic activity were obtained with respect to the influence of the ampakine CX717 (Cortex Pharmaceuticals), using brain imaging and recordings of neuronal activity in NHPs and measures of intracellular calcium release in rat hippocampal slices.
Results: Activation of DLPFC, MTL, and DStr reflected changes in performance related to cognitive load within the DMS task and were engaged primarily on high load trials. Similar increased activation patterns and improved performance were also observed following administration of CX717. Sleep deprivation in NHPs produced impaired performance and reductions in brain activation which was reversed by CX717. One potential basis for this facilitation of cognition by CX717 was increased firing of task-specific hippocampal cells. Synaptic mechanisms affected by CX717 were examined in rat hippocampal slices which showed that N-methyl-D-aspartic acid-mediated release of intracellular calcium was reduced in slices from sleep-deprived rats and reversed by application of CX717 to the bathing medium.
Conclusions: The findings provide insight into how cognition is enhanced by CX717 in terms of brain, and underlying neural, processes that are activated on high vs. low cognitive load trials.
Figures







Similar articles
-
Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates.PLoS Biol. 2005 Sep;3(9):e299. doi: 10.1371/journal.pbio.0030299. Epub 2005 Aug 23. PLoS Biol. 2005. PMID: 16104830 Free PMC article.
-
Acute sleep deprivation: the effects of the AMPAKINE compound CX717 on human cognitive performance, alertness and recovery sleep.J Psychopharmacol. 2012 Aug;26(8):1047-57. doi: 10.1177/0269881111405353. Epub 2011 Sep 22. J Psychopharmacol. 2012. PMID: 21940760 Clinical Trial.
-
Effects of the putative cognitive-enhancing ampakine, CX717, on attention and object recognition memory.Curr Alzheimer Res. 2011 Dec;8(8):876-82. doi: 10.2174/156720511798192709. Curr Alzheimer Res. 2011. PMID: 22171951
-
Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease.Behav Brain Res. 1997 Feb;83(1-2):15-23. doi: 10.1016/s0166-4328(97)86040-8. Behav Brain Res. 1997. PMID: 9062655 Review.
-
[Hippocampus: a target for cognition enhancers].Eksp Klin Farmakol. 2007 Jul-Aug;70(4):59-65. Eksp Klin Farmakol. 2007. PMID: 18078044 Review. Russian.
Cited by
-
Closing the loop in primate prefrontal cortex: inter-laminar processing.Front Neural Circuits. 2012 Nov 22;6:88. doi: 10.3389/fncir.2012.00088. eCollection 2012. Front Neural Circuits. 2012. PMID: 23189041 Free PMC article.
-
Distinct pro-vigilant profile induced in rats by the mGluR5 potentiator LSN2814617.Psychopharmacology (Berl). 2015 Nov;232(21-22):3977-89. doi: 10.1007/s00213-015-3936-8. Epub 2015 Apr 24. Psychopharmacology (Berl). 2015. PMID: 25902875 Free PMC article.
-
The likelihood of cognitive enhancement.Pharmacol Biochem Behav. 2011 Aug;99(2):116-29. doi: 10.1016/j.pbb.2010.12.024. Epub 2011 Jan 6. Pharmacol Biochem Behav. 2011. PMID: 21215768 Free PMC article. Review.
-
Allosteric Modulation of Ionotropic Glutamate Receptors: An Outlook on New Therapeutic Approaches To Treat Central Nervous System Disorders.ACS Med Chem Lett. 2019 Jan 23;10(3):228-236. doi: 10.1021/acsmedchemlett.8b00450. eCollection 2019 Mar 14. ACS Med Chem Lett. 2019. PMID: 30891118 Free PMC article.
-
Control of sleep and wakefulness.Physiol Rev. 2012 Jul;92(3):1087-187. doi: 10.1152/physrev.00032.2011. Physiol Rev. 2012. PMID: 22811426 Free PMC article. Review.
References
-
- Arai AC, Kessler M, Rogers G, Lynch G. Effects of the potent ampakine CX614 on hippocampal and recombinant AMPA receptors: interactions with cyclothiazide and GYKI 52466. Mol Pharmacol. 2000;58:802–813. - PubMed
-
- Arai AC, Xia YF, Rogers G, Lynch G, Kessler M. Benzamide-type AMPA receptor modulators form two subfamilies with distinct modes of action. J Pharmacol Exp Ther. 2002;303:1075–1085. - PubMed
-
- Bachevalier J, Mishkin M. Visual recognition impairment follows ventromedial but not dorsolateral prefrontal lesions in monkeys. Behav Brain Res. 1986;20:249–261. - PubMed
-
- Barcelo F, Suwazono S, Knight RT. Prefrontal modulation of visual processing in humans. Nat Neurosci. 2000;3:399–403. - PubMed
-
- Black KJ, Koller JM, Snyder AZ, Perlmutter JS. Template images for nonhuman primate neuroimaging: 2. Macaque. NeuroImage. 2001;14:744–748. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 DA023573/DA/NIDA NIH HHS/United States
- MH61397/MH/NIMH NIH HHS/United States
- DA06634/DA/NIDA NIH HHS/United States
- R01 MH061397/MH/NIMH NIH HHS/United States
- R01 DA026487/DA/NIDA NIH HHS/United States
- DA023573/DA/NIDA NIH HHS/United States
- R01 DA007625/DA/NIDA NIH HHS/United States
- DA09085/DA/NIDA NIH HHS/United States
- DA08549/DA/NIDA NIH HHS/United States
- R01 DA008549-14A1/DA/NIDA NIH HHS/United States
- Z01 DA000119/Intramural NIH HHS/United States
- K05 DA000119/DA/NIDA NIH HHS/United States
- R01 DA008549/DA/NIDA NIH HHS/United States
- P50 DA006634/DA/NIDA NIH HHS/United States
- R01 DA009085/DA/NIDA NIH HHS/United States
- DA07625/DA/NIDA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources